Skip to main content
Clinical Trials/NCT00617006
NCT00617006
Completed
Not Applicable

Before and After Study Evaluating Deployment of the Sprixx GJ Personal Hand Hygiene Device in the Intra-Operative Environment

Dartmouth-Hitchcock Medical Center1 site in 1 country114 target enrollmentJuly 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nosocomial Infections
Sponsor
Dartmouth-Hitchcock Medical Center
Enrollment
114
Locations
1
Primary Endpoint
The presence of a positive culture on the previously sterile patient stopcock set, and the presence of multidrug resistant bacteria
Status
Completed
Last Updated
18 years ago

Overview

Brief Summary

We hypothesized that by improving hand hygiene compliance in the operative environment, we would reduce horizontal transmission of pathogenic bacteria to surgical patients.

Detailed Description

We performed an observational study evaluating provider adherence to these techniques. We then sought to increase hand hygiene compliance through the use of a point of care alcohol based hand hygiene device. We hypothesized that increased hand hygiene compliance would reduce bacterial contamination of the anesthesia workspace and peripheral intravenous tubing, and ultimately reducing overall morbidity and mortality secondary to a reduction in nosocomial infection rates.

Registry
clinicaltrials.gov
Start Date
July 2007
End Date
October 2007
Last Updated
18 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients present in operating rooms randomized to study.

Exclusion Criteria

  • Patients that were already enrolled in study and return to the operating room.

Outcomes

Primary Outcomes

The presence of a positive culture on the previously sterile patient stopcock set, and the presence of multidrug resistant bacteria

Time Frame: Beginning and end of surgical case

Secondary Outcomes

  • Reduction of bacterial contamination on predetermined sites on the anesthesia machine(Beginning and End of Surgical Case)
  • Nosocomial infection rates(within 30 days postoperatively)
  • Mortality(Within 30 days postoperatively)
  • Decreased length of stay(Postoperatively)

Study Sites (1)

Loading locations...

Similar Trials